title: Setting the bar for adjuvant treatment of melanoma.
authors.affiliation: Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Electronic address: vernon.sondak@moffitt.org.
authors.forename: Vernon K
authors.initials: VK
authors.lastname: Sondak
authors.affiliation: Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA; Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
authors.forename: Geoffrey T
authors.initials: GT
authors.lastname: Gibney
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab